Form4insider filings, from the source

SEC Form 3 · accession 0001012975-17-000160

Sierra Oncology, Inc. · SRRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Nader J Naini
10% Owner
FHM VI, L.P.
10% Owner
Period of report
Feb 14, 2017
Accepted (ET)
Feb 24, 2017 · 3:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001290149

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———2,186,195D
Common StockF2holding———5,925,926D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

This statement is filed by: (i) Frazier Healthcare VI, L.P. ("Frazier VI") and Frazier Life Sciences VIII, L.P. ("Frazier VIII"), each a Delaware limited partnership and direct owners of the shares of Common Stock (together, the "Shares"); (ii) FHM VI, L.P., a Delaware limited partnership and general partner to Frazier VI; FHM VI, LLC a Delaware limited liability company and general partner of FHM VI, L.P.; FHM Life Sciences VIII, L.P., a Delaware limited partnership and general partner to Frazier VIII; and FHM Life Sciences VIII, LLC, a Delaware limited liability company and general partner of FHM Life Sciences VIII, L.P.;and (iii) Alan Frazier, Nader Naini, Nathan Every and Patrick Heron, each of who are members of FHM VI, LLC and may be deemed to share voting and investment power with respect to shares held by Frazier VI and Patrick Heron, who is a member of FHM Life Sciences VIII, LLC and may be deemed to share voting and investment power with respect to shares held by Frazier VIII.